Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Gastric ulcer? 119 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 119 reports of Gastric ulcer have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 0.3% of all adverse event reports for DABIGATRAN ETEXILATE.

119
Reports of Gastric ulcer with DABIGATRAN ETEXILATE
0.3%
of all DABIGATRAN ETEXILATE reports
14
Deaths
97
Hospitalizations

How Dangerous Is Gastric ulcer From DABIGATRAN ETEXILATE?

Of the 119 reports, 14 (11.8%) resulted in death, 97 (81.5%) required hospitalization, and 12 (10.1%) were considered life-threatening.

Is Gastric ulcer Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABIGATRAN ETEXILATE. However, 119 reports have been filed with the FAERS database.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Death (1,025) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861)

What Other Drugs Cause Gastric ulcer?

ASPIRIN (840) IBUPROFEN (828) ADALIMUMAB (631) DICLOFENAC (558) METHOTREXATE (485) NAPROXEN (457) RIVAROXABAN (355) APIXABAN (344) PREDNISONE (323) RITUXIMAB (296)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Gastric ulcer Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Gastric ulcer Reports All Drugs Causing Gastric ulcer DABIGATRAN ETEXILATE Demographics